TAI Diagnostics' Series B Round

TAI Diagnostics raised a round of funding on October 19, 2017.

TAI Diagnostics biotechnology company focused on providing a non-invasive and highly sensitive diagnostic test to monitor the health of transplanted organs in patients who have received solid organ tr…

Articles about TAI Diagnostics' Series B Round: